A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD	Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder	Recruiting	Phase 2	2026-01-20		NCT07351734

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Joincare Pharmaceutical Group Industry Co., Ltd	5

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Guangzhou Medical University	Guangzhou	China	34

Clinical trials